Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 164.50
-4.00 (-2.37%)
Aug 12, 2025, 1:57 PM CST
Altair Engineering Market Cap
Lin BioScience has a market cap or net worth of 13.94 billion as of August 11, 2025. Its market cap has increased by 64.14% in one year.
Market Cap
13.94B
Enterprise Value
11.26B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$164.50
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 13.94B, an increase of 378.01%. That is a compound annual growth rate of 25.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 13.94B | 28.93% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | 6.99B | 284.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Center Laboratories | 27.03B |
| Pegavision | 24.80B |